FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Golden State Medical Supply Ezetimibe and Simvastatin Tablets Recall

Ezetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles, Rx only, Manufacture…

Golden State Medical Supply Inc. · Camarillo, CA

Risk level
Class II
Reported by FDA
Nov 17, 2021
Recall ID
D-0228-2022
Check your lot numberHow we source this data

Summary

Golden State Medical Supply recalled Ezetimibe and Simvastatin Tablets starting Oct 14, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0228-2022 on Nov 17, 2021. Reason: Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity. Status: Terminated.

Why it was recalled

Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity

Product description

Ezetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA 71106 USA, Packaged by GSMS, Incorporated Camarillo, CA 93012 USA; NDC 51407-193-05

Lot numbers, UPCs & expiration codes

GS040048, Exp: 1/2023

Where it was sold

Distributed to two distributors located in AZ and MO

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0228-2022
Classification
Class II
Status
Terminated
Recall initiated
Oct 14, 2021
FDA report date
Nov 17, 2021
Quantity
49
Recall type
Voluntary: Firm initiated
Recalling firm
Golden State Medical Supply Inc.

Original FDA data

Every field from FDA enforcement report D-0228-2022, exactly as published.

Show all FDA fields
City
Camarillo
State
CA
Status
Terminated
Country
United States
Event ID
88866
Address
5187 Camino Ruiz
Code information
GS040048, Exp: 1/2023
Postal code
93012-8601
Report date
Nov 17, 2021
Product type
Drugs
Recall number
D-0228-2022
Classification
Class II
Recalling firm
Golden State Medical Supply Inc.
Product quantity
49
Termination date
Nov 10, 2022
Reason for recall
Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ezetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA 71106 USA, Packaged by GSMS, Incorporated Camarillo, CA 93012 USA; NDC 51407-193-05
Distribution pattern
Distributed to two distributors located in AZ and MO
Recall initiation date
Oct 14, 2021
Initial firm notification
Letter
Center classification date
Nov 9, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0228-2022, published Nov 17, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls